These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3568538)

  • 1. Acute, single, intravenous doses of cibenzoline: an evaluation of safety, tolerance, and hemodynamic effects.
    Humen DP; Lesoway R; Kostuk WJ
    Clin Pharmacol Ther; 1987 May; 41(5):537-45. PubMed ID: 3568538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of a new antiarrhythmic agent: cibenzoline.
    Rigaud M; Jouret G; Canal M; Bardet J; Flouvat B; Bourdarias JP
    J Pharmacol; 1985; 16(3):247-57. PubMed ID: 4068726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of intravenous cibenzoline for acute termination of spontaneous sustained ventricular tachycardia. Cibenzoline and spontaneous VT.
    Chevalier P; Dacosta A; Chalvidan T; Bonnefoy E; Kirkorian G; Isaaz K; Touboul P
    Int J Cardiol; 1998 May; 64(3):265-70. PubMed ID: 9672407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
    Wasty N; Saksena S; Barr MJ
    Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of ATP sensitive potassium channels in heart and pancreatic beta cells using Vaughan-Williams class Ia antiarrhythmics.
    Horie M; Hayashi S; Yuzuki Y; Sasayama S
    Cardiovasc Res; 1992 Nov; 26(11):1087-94. PubMed ID: 1291086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single infusion of intravenous cibenzoline in the treatment of supraventricular tachyarrhythmias following heart surgery. A double-blind placebo-controlled parallel study.
    Ollitrault J; Quilliet L; Scheck F; Lelong B; Richard A; Jarry G; Guize L
    Eur Heart J; 1994 Sep; 15(9):1274-8. PubMed ID: 7982430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of cibenzoline on normal myocardium and after pretreatment with DL-sotalol.
    Beyer ME; Hoffmeister HM; Seipel L
    J Cardiovasc Pharmacol; 1992 May; 19(5):657-64. PubMed ID: 1381761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.
    Canal M; Flouvat B; Tremblay D; Dufour A
    Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antiarrhythmic therapy with cibenzoline.
    Mohiuddin SM; Hilleman DE; Esterbrooks D; Mooss AN; Stengel LA
    J Clin Pharmacol; 1987; 27(5):400-6. PubMed ID: 3693585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of the antiarrhythmic drug pirmenol.
    Phillips HR; Stack RS; Davis DD; Morris KG; Lee KL; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1982 Aug; 32(2):235-9. PubMed ID: 7094511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
    Hermida JS; Mabo P; Rouesnel P; Scheck F; Canler A; Barthélémy M; Wanszelbaum H
    Ann Cardiol Angeiol (Paris); 1995 Jan; 44(1):49-55. PubMed ID: 7702357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.
    Hamada M; Ikeda S; Ohshima K; Nakamura M; Kubota N; Ogimoto A; Shigematsu Y
    J Cardiol; 2016 Mar; 67(3):279-86. PubMed ID: 26116980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteers.
    Brazzell RK; Khoo KC; Szuna AJ; Sandor D; Aogaichi K; Wills RJ
    J Clin Pharmacol; 1985 Sep; 25(6):418-23. PubMed ID: 4056077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
    Atarashi H; Iida K; Kou M; Hirayama Y; Gotoh M; Ino T; Katoh T; Hayakawa H
    Kokyu To Junkan; 1988 Oct; 36(10):1119-24. PubMed ID: 3247527
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog.
    Keren G; Tepper D; Butler B; Miura D; Aogaichi K; Somberg J
    J Clin Pharmacol; 1984 Oct; 24(10):466-72. PubMed ID: 6511989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cibenzoline in patients with renal impairment.
    Canal M; Flouvat B; Aubert P; Guedon J; Prinseau J; Baglin A
    J Clin Pharmacol; 1985 Apr; 25(3):197-203. PubMed ID: 3998200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dosing interval and optimum dose of cibenzoline.
    Zempol P; Aogaichi K; Butler B; Tepper D; Somberg JC
    J Clin Pharmacol; 1987 Sep; 27(9):666-72. PubMed ID: 3680596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.